Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 10, 2025International Journal of Application on Economics and Business

Comparative Analysis of Financial Performance of Pharmaceutical Companies During and After the Covid-19 Pandemic

View Full Paper
Ask AI
Bookmark
Share

Authors

KNKhairina NatsirTarumanagara UniversityNBNurainun BangunTarumanagara University

Discussion

Loading...

Member takes

Implication

Comparative analysis shows no significant difference in financial indicators among companies on IDX, highlighting post-pandemic adaptations.

Key Points

  • The financial performance analysis reveals no significant differences in profitability and liquidity across the two periods.
  • Profitability was assessed using Return on Assets and Net Profit Margin, while liquidity was measured by the Current Ratio.
  • Using the paired sample t-test, the study observed variations in Debt to Equity Ratio, indicating changes post-pandemic.
  • The sample comprised 11 pharmaceutical companies listed on the Indonesia Stock Exchange during 2020-2023.

Cite This Study

Natsir et al. (2025) studied this question.

synapsesocial.com/papers/68e861857ef2f04ca37e3c77https://doi.org/10.24912/ijaeb.v3i3.1245-1259
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparative Analysis of Pharmaceutical Company's Financial Perfomance Before and During Covid-19 Crisis2025
  2. 2Analysis of the Impact of the COVID-19 Pandemic on Financial Performance in Various Industrial Sectors in Indonesia2025
  3. 3THE IMPACT OF THE COVID 19 PANDEMIC ON COMPANY FINANCIAL PERFORMANCE (Case Study of a Food & Beverage Company listed on the IDX)2024
  4. 4Comparative Analysis of Financial Ratio Before and During the Covid-19 Pandemic in Retail Trade Companies in Indonesia Before and During the Covid-19 Pandemic2024
  5. 5The Analysis of Financial Performance of Tourism Sector Company Listed on the Indonesian Stock Exchange Before and During the COVID-19 Pandemic2024